Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors
Neurooncol Adv
.
2023 Apr 14;5(1):vdad029.
doi: 10.1093/noajnl/vdad029.
eCollection 2023 Jan-Dec.
Authors
HyeRim Han
1
2
,
Samuele Renzi
3
,
Valerie Larouche
3
,
Damien Faury
4
,
Sylvie Langlois
5
,
Daniel Sinnett
5
6
,
Andrea Gomez
7
,
Jason Karamchandani
7
,
Louis Crevier
8
,
William D Foulkes
2
9
10
,
Nada Jabado
2
4
Affiliations
1
Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
2
Department of Human Genetics, McGill University Faculty of Medicine, Montreal, Québec, Canada.
3
Department of Pediatric and Division of Hemato-Oncology, CHU de Québec-Université-Laval, Québec, Canada.
4
Department of Pediatrics, McGill University and McGill University Heath Centre Research Institute, Montreal, Quebec, Canada.
5
Division of Hematology-Oncology, Research Center, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, Canada.
6
Department of Pediatrics, University of Montreal, Faculty of Medicine, Montreal, Quebec, Canada.
7
Department of Pathology, McGill University, Montreal, Quebec, Canada.
8
Department of Surgery, CHU de Québec-Université-Laval, Québec, Canada.
9
Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.
10
Department of Human Genetics, McGill University and McGill University Heath Centre Research Institute, Montreal, Quebec, Canada.
PMID:
37114246
PMCID:
PMC10129385
DOI:
10.1093/noajnl/vdad029
No abstract available